Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.    

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CHF)
Sales 2015 48 026 M
EBIT 2015 17 047 M
Net income 2015 10 774 M
Debt 2015 11 108 M
Yield 2015 2,97%
Sales 2016 50 213 M
EBIT 2016 18 289 M
Net income 2016 12 081 M
Debt 2016 6 948 M
Yield 2016 3,16%
PER 2015 21,90
PER 2016 19,52
EV / Sales 2015 5,24x
EV / Sales 2016 4,93x
Capitalization 240 717 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
08/13Presentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
07/23DJBristol-Myers Revenue Boosted by Cancer Drug Opdivo
07/23DJBristol-Myers Gets a Revenue Boost from Opdivo
07/23DJRoche Battered by Strong Swiss Franc -- Update
07/23DJRoche Battered by Strong Swiss Franc
07/23DJRoche Battered by Strong Swiss Franc
07/22DJLilly's Alzheimer's Drug May Slow Patients' Decline, Study Shows -- Update
07/20DJRoche Holding AG HY 2015 -- Forecast
07/16 Immunocore raises $320 million in record financing round
More news
Sector news : Pharmaceuticals - NEC
06:06p TARO PHARMACEUTICAL : to Announce First Quarter Results on August 6, 2015
05:52pDJAmgen Raises 2015 Outlook, Results Beat Expectations -- 2nd Update
04:51p Amgen profit tops Street view, boosts full-year forecast
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions